NFKB1 and myeloid sarcoma: Activation of AhR significantly inhibited NFκB signaling, reduced levels of downstream inflammatory cytokines like TNF-α, IL6 and CCL2 and relieved CNS inflammation in MS models, while AhR deletion resulted in increased nuclear localization of NFκB in microglia [10, 11].